Global Peripheral Stents Market Size By Type (Balloon-expandable, Self-expandable), By Application (SFA, PPA), By Region, And Segment Forecasts, 2023 to 2032

The Global Peripheral Stents Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 7.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2023 to 2031. Peripheral stents are used to treat narrowed or blocked arteries outside of the heart, particularly in the legs, arms, and kidneys. The increasing incidence of peripheral artery disease (PAD), growing geriatric population, advancements in stent technology, and rising preference for minimally invasive procedures are key factors propelling market growth. Additionally, increasing awareness and access to healthcare in emerging markets contribute significantly to the expansion of this market.

Drivers:

1. Increasing Prevalence of Peripheral Artery Disease (PAD):

The rising global burden of PAD, driven by aging populations, diabetes, and smoking, is significantly increasing the demand for peripheral stenting procedures.

2. Technological Advancements in Stents:

Innovation in materials (e.g., nitinol, drug-eluting coatings), bioresorbable stents, and improved delivery systems are enhancing clinical outcomes and broadening the adoption of peripheral stents.

3. Shift Towards Minimally Invasive Procedures:

The healthcare industry’s increasing preference for endovascular procedures over open surgeries due to faster recovery times and reduced hospital stays is boosting market demand.

Restraints:

1. High Cost of Advanced Stent Systems:

The substantial cost associated with drug-eluting and next-generation stents limits their affordability and adoption, particularly in low-income regions.

2. Regulatory Challenges and Product Recalls:

Stringent regulatory frameworks and occasional recalls due to product failures can hinder market expansion and manufacturer reputation.

Opportunity:

1. Growing Demand in Emerging Markets:

Asia-Pacific and Latin America are witnessing increased healthcare expenditure, improving infrastructure, and heightened awareness, creating lucrative opportunities for peripheral stent manufacturers.

2. Development of Biodegradable and Smart Stents:

Innovations in stent design, such as fully biodegradable stents and stents with embedded sensors for real-time monitoring, are opening new avenues for clinical use and commercial adoption.

Market by System Type Insights:

In 2023, balloon-expandable stents held the largest share in the peripheral stents market due to their precision in deployment and suitability for a wide range of lesions. However, self-expanding stents are anticipated to witness the fastest growth owing to their flexibility and superior performance in tortuous arteries, especially in the superficial femoral and iliac arteries.

Market by End-use Insights:

Hospitals dominated the market in 2023, accounting for over 60% of global revenue. This is attributed to the availability of advanced surgical and imaging technologies, coupled with skilled healthcare professionals. Ambulatory surgical centers (ASCs) are expected to exhibit the highest growth due to the increasing adoption of outpatient vascular procedures and cost-effective care.

Market by Regional Insights:

North America led the global peripheral stents market in 2023, driven by high prevalence of PAD, favorable reimbursement policies, and advanced healthcare infrastructure. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period, fueled by a growing patient base, rising healthcare investments, and increased medical tourism.

Competitive Scenario:

Key players in the global peripheral stents market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

BD (Becton, Dickinson and Company)

Cook Medical

Terumo Corporation

Biotronik SE & Co. KG

Cordis

iVascular

MicroPort Scientific Corporation

These companies are focusing on new product launches, regulatory approvals, and strategic collaborations to strengthen their global footprint. For example:

In 2024, Abbott launched a next-gen drug-eluting peripheral stent with enhanced deliverability and longer lesion coverage.

Boston Scientific received FDA approval in 2023 for its advanced polymer-coated stent designed to minimize restenosis.

Scope of Work – Global Peripheral Stents Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 7.4 billion

CAGR (2023–2031) 7.5%

Market Segments By System Type (Balloon-Expandable, Self-Expanding), By End-use (Hospitals, ASCs, Others), By Region

Growth Drivers Increasing PAD prevalence, Technological Advancements, Rise in Minimally Invasive Procedures

Opportunities Emerging markets expansion, Smart/Biodegradable Stents Development

Key Market Developments:

June 2024: Cook Medical introduced a flexible peripheral self-expanding stent system targeting superficial femoral artery (SFA) lesions.

April 2023: Terumo Corporation partnered with a leading interventional radiology group to conduct clinical trials for its bioresorbable peripheral stent.

August 2023: Medtronic launched a global education program for vascular surgeons focused on next-gen stenting technologies.

FAQs:

1) What is the current market size of the Global Peripheral Stents Market?

The Global Peripheral Stents Market was valued at USD 4.1 billion in 2023.

2) What is the major growth driver of the Global Peripheral Stents Market?

The increasing prevalence of peripheral artery disease and advancements in stent technology are the primary growth drivers.

3) Which is the largest region during the forecast period in the Global Peripheral Stents Market?

North America is the largest region due to high disease incidence, reimbursement support, and advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in the Global Peripheral Stents Market?

The balloon-expandable stents segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Peripheral Stents Market?

Key players include Medtronic plc, Boston Scientific, Abbott Laboratories, BD, Cook Medical, Terumo, and others.